ATE535617T1 - Verfahren zur prognostischen bestimmung von chemotherapie, basierend auf einem verlust an heterozygosität (loh) des thymidilatsynthase locus - Google Patents

Verfahren zur prognostischen bestimmung von chemotherapie, basierend auf einem verlust an heterozygosität (loh) des thymidilatsynthase locus

Info

Publication number
ATE535617T1
ATE535617T1 AT04713289T AT04713289T ATE535617T1 AT E535617 T1 ATE535617 T1 AT E535617T1 AT 04713289 T AT04713289 T AT 04713289T AT 04713289 T AT04713289 T AT 04713289T AT E535617 T1 ATE535617 T1 AT E535617T1
Authority
AT
Austria
Prior art keywords
heterozygosity
loh
loss
chemotherapy based
thymidilate synthase
Prior art date
Application number
AT04713289T
Other languages
English (en)
Inventor
Kathleen Danenberg
Original Assignee
Response Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Response Genetics Inc filed Critical Response Genetics Inc
Application granted granted Critical
Publication of ATE535617T1 publication Critical patent/ATE535617T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04713289T 2003-02-27 2004-02-20 Verfahren zur prognostischen bestimmung von chemotherapie, basierend auf einem verlust an heterozygosität (loh) des thymidilatsynthase locus ATE535617T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/373,752 US20040170983A1 (en) 2003-02-27 2003-02-27 Methods of determining a chemotherapuetic regimin based on loss of heterozygosity at the thymidylate synthase locus
PCT/US2004/004867 WO2004075833A2 (en) 2003-02-27 2004-02-20 Methods of determining a chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase locus

Publications (1)

Publication Number Publication Date
ATE535617T1 true ATE535617T1 (de) 2011-12-15

Family

ID=32907701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04713289T ATE535617T1 (de) 2003-02-27 2004-02-20 Verfahren zur prognostischen bestimmung von chemotherapie, basierend auf einem verlust an heterozygosität (loh) des thymidilatsynthase locus

Country Status (15)

Country Link
US (1) US20040170983A1 (de)
EP (1) EP1597393B1 (de)
JP (1) JP2006520197A (de)
KR (1) KR101109062B1 (de)
CN (1) CN1777685A (de)
AR (1) AR043398A1 (de)
AT (1) ATE535617T1 (de)
AU (1) AU2004216231B2 (de)
CA (1) CA2517384C (de)
ES (1) ES2377062T3 (de)
IL (1) IL170217A (de)
MX (1) MXPA05009162A (de)
NZ (1) NZ542500A (de)
TW (1) TWI346701B (de)
WO (1) WO2004075833A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2704303T3 (es) 2010-08-24 2019-03-15 Dana Farber Cancer Inst Inc Procedimientos para la predicción de una respuesta contra el cáncer
ES2768344T3 (es) 2011-06-17 2020-06-22 Myriad Genetics Inc Métodos y materiales para evaluar el desequilibrio alélico
JP6325453B2 (ja) 2011-12-21 2018-05-16 ミリアド・ジェネティックス・インコーポレイテッド ヘテロ接合性の消失(lossofheterozygosity)を評価するための方法および材料
ES2687024T3 (es) 2012-02-23 2018-10-23 Children's Medical Center Corporation Procedimientos para predecir la respuesta contra el cáncer
CA2867434C (en) 2012-06-07 2021-10-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
CA2931181C (en) 2013-12-09 2023-01-24 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
DK3686288T3 (da) 2014-08-15 2023-05-22 Myriad Genetics Inc Fremgangsmåder og materialer til analyse af homolog rekombinationsdeficiens
CN108459157B (zh) * 2018-01-11 2020-11-27 中国药科大学 一种预测伊立替康化疗毒性生物标志物的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998151A (en) * 1995-12-01 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase

Also Published As

Publication number Publication date
CA2517384C (en) 2013-01-22
EP1597393A2 (de) 2005-11-23
US20040170983A1 (en) 2004-09-02
WO2004075833A3 (en) 2004-11-11
KR20050105498A (ko) 2005-11-04
ES2377062T3 (es) 2012-03-22
AR043398A1 (es) 2005-07-27
AU2004216231B2 (en) 2009-07-23
AU2004216231A1 (en) 2004-09-10
WO2004075833A2 (en) 2004-09-10
CA2517384A1 (en) 2004-09-10
TW200510546A (en) 2005-03-16
KR101109062B1 (ko) 2012-01-31
MXPA05009162A (es) 2005-10-26
JP2006520197A (ja) 2006-09-07
TWI346701B (en) 2011-08-11
CN1777685A (zh) 2006-05-24
EP1597393B1 (de) 2011-11-30
NZ542500A (en) 2008-04-30
IL170217A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
DE502004000787D1 (de) Verfahren zur Umsetzung von Polyorganosiloxanen
DE502004009763D1 (de) Verfahren zur herstellung von 1-buten
DE60325195D1 (de) Verfahren zur vorhersage von wiederkehrenden ventrikulären arrhythmien
DE50307672D1 (de) Verfahren zur herstellung von polycarbonaten
ATE507305T1 (de) Verfahren zur nukleinsäureimmobilisierung
WO2007081720A3 (en) Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
EP2115158A4 (de) Datenverarbeitung, analyseverfahren für genexpressionsdaten zur identifizierung endogener referenzgene
ATE524393T1 (de) Verfahren zur zubereitung von getränken
DE60328522D1 (de) Verfahren zur herstellung von bisphenol
ATE469908T1 (de) Verfahren zur herstellung von pimecrolimus
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE60234425D1 (de) Verfahren zur optimaliserung von verkerhrsinformationsinhalt
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE502004005149D1 (de) Fräsverfahren zur fertigung von bauteilen
DE60302139D1 (de) Verfahren zur herstellung von aripiprazole
DE502005003004D1 (de) Verfahren zur herstellung von polycarbonat
ATE380811T1 (de) Verfahren zur herstellung von 1-(2s,3s)-2- benzhydril-n-(5-tert.-butyl-2- methoxybenzyl)chinuklidin-3-amin
WO2005118879A3 (en) Identification of tumors
DE60206969D1 (de) System zur vermittlung von fehlererfassungsdaten
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
ATE531834T1 (de) Verfahren zur mehrstufigen direkten elektrolytischen gewinnung von kupfer
DE502004009594D1 (de) Verfahren zur Übertragung von Sensordaten
FI20031733A0 (fi) Menetelmä kuparielektrolyysin tilaindeksin määrittämiseksi
DE502005003098D1 (de) Verfahren zur herstellung von polycarbonat
DE112005002353B8 (de) Verfahren zur Herstellung von Sammelleitungen aus Kupfer